Mitesh

The new FreeStyle Libre® 2 Plus sensors recently launched by Abbott Diabetes Care Ltd have been added to the Appliances section in Part IXA of the April 2024 Drug Tariff.  At the same time, the sensors have also been included in the Drugs for which Discount is Not Deducted (DND) list (Part II of the Drug Tariff). [...]

The post Newly launched FreeStyle Libre® 2 Plus Sensors enter the Drug Tariff and DND list from April 2024 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) is currently unable to confirm whether or not NHS prescription charges will be uplifted in 2024. The NHS prescription charge and the cost of Prescription Pre-payment Certificates (PPCs) are reviewed annually with changes usually made in April, but this year the Government has yet to conclude consideration [...]

The post NHS prescription charge of £9.65 to roll over into April appeared first on Community Pharmacy England.

With Easter Monday (1 April 2024) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 April 2024, to submit their March FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing division at the [...]

The post Extended FP34C submission deadline for prescriptions dispensed in March 2024 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Monomil® XL 60mg tablets (SSP059). SSP059 was due to expire on 31 May 2024 but the end date has been further extended to Friday 7 June 2024. The Department of Health and Social Care (DHSC) has [...]

The post SSP059 for Monomil® XL 60mg tablets extended appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) Drug alert number: EL (24)A/07 Date issued: 26 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm [...]

The post MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) appeared first on Community Pharmacy England.